^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Rectal Cancer |
| Regimen: | FOLFIRINOX (5-fluorouracil + irinotecan + leucovorin calcium + oxaliplatin) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
02/25/2022
Excerpt:
Rectal cancer: CONTINUUM OF CARE - SYSTEMIC THERAPY FOR ADVANCED OR METASTATIC DISEASE...Patient appropriate for intensive therapy…Initial therapy...FOLFIRINOX ± bevacizumab
